Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.

Went M, Sud A, Speedy H, Sunter NJ, Försti A, Law PJ, Johnson DC, Mirabella F, Holroyd A, Li N, Orlando G, Weinhold N, van Duin M, Chen B, Mitchell JS, Mansouri L, Juliusson G, Smedby KE, Jayne S, Majid A, Dearden C, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Rosenquist R, Kuiper R, Stephens OW, Bertsch U, Broderick P, Einsele H, Gregory WM, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Nickel J, Nöthen MM, da Silva Filho MI, Thomsen H, Walker BA, Broyl A, Davies FE, Hansson M, Goldschmidt H, Dyer MJS, Kaiser M, Sonneveld P, Morgan GJ, Hemminki K, Nilsson B, Catovsky D, Allan JM, Houlston RS.

Blood Cancer J. 2018 Dec 21;9(1):1. doi: 10.1038/s41408-018-0162-8.

2.

CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL.

Chen Y, Peubez C, Smith V, Xiong S, Kocsis-Fodor G, Kennedy B, Wagner S, Balotis C, Jayne S, Dyer MJS, Macip S.

J Cell Mol Med. 2019 Jan;23(1):340-348. doi: 10.1111/jcmm.13935. Epub 2018 Oct 24.

3.

DNA methylation profiling of hepatosplenic T-cell lymphoma.

Bergmann AK, Fataccioli V, Castellano G, Martin-Garcia N, Pelletier L, Ammerpohl O, Bergmann J, Bhat J, Pau ECS, Martín-Subero JI, Moffitt AB, Valencia A, Oberg HH, Wesch D, Jayne S, Dyer MJS, Kabelitz D, Gaulard P, Siebert R.

Haematologica. 2019 Mar;104(3):e104-e107. doi: 10.3324/haematol.2018.196196. Epub 2018 Oct 18. No abstract available.

4.

Climate Process Team on Internal Wave-Driven Ocean Mixing.

MacKinnon JA, Alford MH, Ansong JK, Arbic BK, Barna A, Briegleb BP, Bryan FO, Buijsman MC, Chassignet EP, Danabasoglu G, Diggs S, Griffies SM, Hallberg RW, Jayne SR, Jochum M, Klymak JM, Kunze E, Large WG, Legg S, Mater B, Melet AV, Merchant LM, Musgrave R, Nash JD, Norton NJ, Pickering A, Pinkel R, Polzin K, Simmons HL, St Laurent LC, Sun OM, Trossman DS, Waterhouse AF, Whalen CB, Zhao Z.

Bull Am Meteorol Soc. 2017 Nov;98(11):2429-2454. doi: 10.1175/BAMS-D-16-0030.1. Epub 2017 Dec 1.

5.

Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines.

Kozaki R, Vogler M, Walter HS, Jayne S, Dinsdale D, Siebert R, Dyer MJS, Yoshizawa T.

Cancers (Basel). 2018 Apr 23;10(4). pii: E127. doi: 10.3390/cancers10040127.

6.

Differential activation of pro-survival pathways in response to CD40LG/IL4 stimulation in chronic lymphocytic leukaemia cells.

Chen Y, Peubez C, Jayne S, Kocsis-Fodor G, Dyer MJS, Macip S.

Br J Haematol. 2019 Mar;184(5):867-869. doi: 10.1111/bjh.15197. Epub 2018 Apr 20. No abstract available.

PMID:
29676456
7.

Percutaneous endoscopic gastrostomy (PEG) versus radiologically inserted gastrostomy (RIG): A comparison of outcomes at an Australian teaching hospital.

Vidhya C, Phoebe D, Dhina C, Jayne S, Robert F.

Clin Nutr ESPEN. 2018 Feb;23:136-140. doi: 10.1016/j.clnesp.2017.10.014. Epub 2017 Nov 27.

PMID:
29460789
8.

Paradoxical activation of alternative pro-survival pathways determines resistance to MEK inhibitors in chronic lymphocytic leukaemia.

Chen Y, Germano S, Shelmani G, Kluczna D, Jayne S, Dyer MJS, Macip S.

Br J Haematol. 2018 Sep;182(6):921-924. doi: 10.1111/bjh.14880. Epub 2017 Aug 2. No abstract available.

PMID:
28771685
9.

Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.

Navarro A, Clot G, Martínez-Trillos A, Pinyol M, Jares P, González-Farré B, Martínez D, Trim N, Fernández V, Villamor N, Colomer D, Costa D, Salaverria I, Martín-Garcia D, Erber W, López C, Jayne S, Siebert R, Dyer MJS, Wiestner A, Wilson WH, Aymerich M, López-Guillermo A, Sánchez À, Campo E, Matutes E, Beà S.

Haematologica. 2017 Sep;102(9):e360-e363. doi: 10.3324/haematol.2016.160374. Epub 2017 May 18. No abstract available.

10.

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

Walter HS, Jayne S, Rule SA, Cartron G, Morschhauser F, Macip S, Karlin L, Jones C, Herbaux C, Quittet P, Shah N, Hutchinson CV, Fegan C, Yang Y, Mitra S, Salles G, Dyer MJS.

Blood. 2017 May 18;129(20):2808-2810. doi: 10.1182/blood-2017-02-765115. Epub 2017 Apr 4. No abstract available.

11.

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.

Law PJ, Berndt SI, Speedy HE, Camp NJ, Sava GP, Skibola CF, Holroyd A, Joseph V, Sunter NJ, Nieters A, Bea S, Monnereau A, Martin-Garcia D, Goldin LR, Clot G, Teras LR, Quintela I, Birmann BM, Jayne S, Cozen W, Majid A, Smedby KE, Lan Q, Dearden C, Brooks-Wilson AR, Hall AG, Purdue MP, Mainou-Fowler T, Vajdic CM, Jackson GH, Cocco P, Marr H, Zhang Y, Zheng T, Giles GG, Lawrence C, Call TG, Liebow M, Melbye M, Glimelius B, Mansouri L, Glenn M, Curtin K, Diver WR, Link BK, Conde L, Bracci PM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Boffetta P, Brennan P, Maynadie M, McKay J, Albanes D, Weinstein S, Wang Z, Caporaso NE, Morton LM, Severson RK, Riboli E, Vineis P, Vermeulen RC, Southey MC, Milne RL, Clavel J, Topka S, Spinelli JJ, Kraft P, Ennas MG, Summerfield G, Ferri GM, Harris RJ, Miligi L, Pettitt AR, North KE, Allsup DJ, Fraumeni JF, Bailey JR, Offit K, Pratt G, Hjalgrim H, Pepper C, Chanock SJ, Fegan C, Rosenquist R, de Sanjose S, Carracedo A, Dyer MJ, Catovsky D, Campo E, Cerhan JR, Allan JM, Rothman N, Houlston R, Slager S.

Nat Commun. 2017 Feb 6;8:14175. doi: 10.1038/ncomms14175.

12.

Posttranscriptional Upregulation of p53 by Reactive Oxygen Species in Chronic Lymphocytic Leukemia.

Samuel J, Jayne S, Chen Y, Majid A, Wignall A, Wormull T, Najeeb H, Luo JL, Jones GD, Macip S, Dyer MJ.

Cancer Res. 2016 Nov 1;76(21):6311-6319. Epub 2016 Sep 7.

13.

Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.

Speedy HE, Kinnersley B, Chubb D, Broderick P, Law PJ, Litchfield K, Jayne S, Dyer MJS, Dearden C, Follows GA, Catovsky D, Houlston RS.

Blood. 2016 Nov 10;128(19):2319-2326. doi: 10.1182/blood-2016-01-695692. Epub 2016 Aug 15.

14.

Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.

Chen Y, Germano S, Clements C, Samuel J, Shelmani G, Jayne S, Dyer MJ, Macip S.

Br J Haematol. 2016 Nov;175(4):641-651. doi: 10.1111/bjh.14285. Epub 2016 Jul 29.

PMID:
27469405
15.

Obinutuzumab-induced coagulopathy in chronic lymphocytic leukaemia with trisomy 12.

Walter HS, Jayne S, Mensah P, Miall FM, Lyttelton M, Dyer MJ.

Blood Cancer J. 2016 Jun 17;6:e435. doi: 10.1038/bcj.2016.42. No abstract available.

16.

A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.

Sbarrato T, Horvilleur E, Pöyry T, Hill K, Chaplin LC, Spriggs RV, Stoneley M, Wilson L, Jayne S, Vulliamy T, Beck D, Dokal I, Dyer MJ, Yeomans AM, Packham G, Bushell M, Wagner SD, Willis AE.

Cell Death Dis. 2016 Jun 2;7(6):e2249. doi: 10.1038/cddis.2016.148.

17.

HHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q.

Zhang E, Cotton VE, Hidalgo-Bravo A, Huang Y, Bell AJ, Jarrett RF, Wilkie GS, Davison AJ, Nacheva EP, Siebert R, Majid A, Kelpanides I, Jayne S, Dyer MJ, Royle NJ.

Sci Rep. 2016 Mar 7;6:22730. doi: 10.1038/srep22730.

18.

Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.

López C, Bergmann AK, Paul U, Murga Penas EM, Nagel I, Betts MJ, Johansson P, Ritgen M, Baumann T, Aymerich M, Jayne S, Russell RB, Campo E, Dyer MJ, Dürig J, Siebert R.

Br J Haematol. 2016 Apr;173(2):265-73. doi: 10.1111/bjh.13952. Epub 2016 Feb 25.

PMID:
26917488
19.

Evidence for cooperative tandem binding of hnRNP C RRMs in mRNA processing.

Cieniková Z, Jayne S, Damberger FF, Allain FH, Maris C.

RNA. 2015 Nov;21(11):1931-42. doi: 10.1261/rna.052373.115. Epub 2015 Sep 14.

20.

Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.

Salaverria I, Martín-Garcia D, López C, Clot G, García-Aragonés M, Navarro A, Delgado J, Baumann T, Pinyol M, Martin-Guerrero I, Carrió A, Costa D, Queirós AC, Jayne S, Aymerich M, Villamor N, Colomer D, González M, López-Guillermo A, Campo E, Dyer MJ, Siebert R, Armengol L, Beà S.

Genes Chromosomes Cancer. 2015 Nov;54(11):668-80. doi: 10.1002/gcc.22277. Epub 2015 Aug 25.

21.

Recurrent CDKN1B (p27) mutations in hairy cell leukemia.

Dietrich S, Hüllein J, Lee SC, Hutter B, Gonzalez D, Jayne S, Dyer MJ, Oleś M, Else M, Liu X, Słabicki M, Wu B, Troussard X, Dürig J, Andrulis M, Dearden C, von Kalle C, Granzow M, Jauch A, Fröhling S, Huber W, Meggendorfer M, Haferlach T, Ho AD, Richter D, Brors B, Glimm H, Matutes E, Abdel Wahab O, Zenz T.

Blood. 2015 Aug 20;126(8):1005-8. doi: 10.1182/blood-2015-04-643361. Epub 2015 Jun 11.

22.

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.

Sava GP, Speedy HE, Di Bernardo MC, Dyer MJ, Holroyd A, Sunter NJ, Marr H, Mansouri L, Deaglio S, Karabon L, Frydecka I, Jamroziak K, Woszczyk D, Juliusson G, Smedby KE, Jayne S, Majid A, Wang Y, Dearden C, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Rosenquist R, Catovsky D, Allan JM, Houlston RS.

Leukemia. 2015 Mar;29(3):748-51. doi: 10.1038/leu.2014.311. Epub 2014 Nov 3. No abstract available.

23.

A Double Hit CD10-Negative B-Cell Lymphoma with t(3;8)(q27;q24) Leading to Juxtaposition of the BCL6 and MYC Loci Associated with Good Clinical Outcome.

Sanders L, Jayne S, Kennedy B, Miall F, Aukema SM, Siebert R, Wagner SD, Dyer MJ.

Case Rep Hematol. 2014;2014:120714. doi: 10.1155/2014/120714. Epub 2014 Oct 1.

24.

A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.

Queirós AC, Villamor N, Clot G, Martinez-Trillos A, Kulis M, Navarro A, Penas EM, Jayne S, Majid A, Richter J, Bergmann AK, Kolarova J, Royo C, Russiñol N, Castellano G, Pinyol M, Bea S, Salaverria I, López-Guerra M, Colomer D, Aymerich M, Rozman M, Delgado J, Giné E, González-Díaz M, Puente XS, Siebert R, Dyer MJ, López-Otín C, Rozman C, Campo E, López-Guillermo A, Martín-Subero JI.

Leukemia. 2015 Mar;29(3):598-605. doi: 10.1038/leu.2014.252. Epub 2014 Aug 25.

PMID:
25151957
25.

Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.

Bergmann AK, Schneppenheim S, Seifert M, Betts MJ, Haake A, Lopez C, Maria Murga Penas E, Vater I, Jayne S, Dyer MJ, Schrappe M, Dührsen U, Ammerpohl O, Russell RB, Küppers R, Dürig J, Siebert R.

Genes Chromosomes Cancer. 2014 Apr;53(4):309-16. doi: 10.1002/gcc.22141. Epub 2014 Jan 21.

PMID:
24446122
26.

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.

Speedy HE, Di Bernardo MC, Sava GP, Dyer MJ, Holroyd A, Wang Y, Sunter NJ, Mansouri L, Juliusson G, Smedby KE, Roos G, Jayne S, Majid A, Dearden C, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Rosenquist R, Catovsky D, Allan JM, Houlston RS.

Nat Genet. 2014 Jan;46(1):56-60. doi: 10.1038/ng.2843. Epub 2013 Dec 1.

PMID:
24292274
27.

Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls.

Dyer MJ, Vogler M, Samuel J, Jayne S, Wagner S, Pritchard C, Macip S.

Br J Haematol. 2013 Mar;160(6):725-33. doi: 10.1111/bjh.12219. Epub 2013 Jan 24.

PMID:
23346939
28.

Fukushima-derived radionuclides in the ocean and biota off Japan.

Buesseler KO, Jayne SR, Fisher NS, Rypina II, Baumann H, Baumann Z, Breier CF, Douglass EM, George J, Macdonald AM, Miyamoto H, Nishikawa J, Pike SM, Yoshida S.

Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5984-8. doi: 10.1073/pnas.1120794109. Epub 2012 Apr 2.

29.

A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well.

Daubner GM, Cléry A, Jayne S, Stevenin J, Allain FH.

EMBO J. 2012 Jan 4;31(1):162-74. doi: 10.1038/emboj.2011.367. Epub 2011 Oct 14.

30.

Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-β1.

Cléry A, Jayne S, Benderska N, Dominguez C, Stamm S, Allain FH.

Nat Struct Mol Biol. 2011 Apr;18(4):443-50. doi: 10.1038/nsmb.2001. Epub 2011 Mar 13.

PMID:
21399644
31.

CARM1 but not its enzymatic activity is required for transcriptional coactivation of NF-kappaB-dependent gene expression.

Jayne S, Rothgiesser KM, Hottiger MO.

J Mol Biol. 2009 Dec 4;394(3):485-95. doi: 10.1016/j.jmb.2009.09.032. Epub 2009 Sep 19.

PMID:
19769987
32.
33.

Crystallization of a proteolyzed form of the horse pancreatic lipase-related protein 2: structural basis for the specific detergent requirement.

Mancheño JM, Jayne S, Kerfelec B, Chapus C, Crenon I, Hermoso JA.

Acta Crystallogr D Biol Crystallogr. 2004 Nov;60(Pt 11):2107-9. Epub 2004 Oct 20.

PMID:
15502342
34.

Repression of promoter activity by CNOT2, a subunit of the transcription regulatory Ccr4-not complex.

Zwartjes CG, Jayne S, van den Berg DL, Timmers HT.

J Biol Chem. 2004 Mar 19;279(12):10848-54. Epub 2004 Jan 5.

35.

Characterisation of the expression of a novel constitutive maize promoter in transgenic wheat and maize.

Rasco-Gaunt S, Liu D, Li CP, Doherty A, Hagemann K, Riley A, Thompson T, Brunkan C, Mitchell M, Lowe K, Krebbers E, Lazzeri P, Jayne S, Rice D.

Plant Cell Rep. 2003 Feb;21(6):569-76. Epub 2002 Nov 16.

PMID:
12789432
36.

Activation of horse PLRP2 by bile salts does not require colipase.

Jayne S, Kerfelec B, Foglizzo E, Granon S, Hermoso J, Chapus C, Crenon I.

Biochemistry. 2002 Jul 2;41(26):8422-8.

PMID:
12081491
37.

High expression in adult horse of PLRP2 displaying a low phospholipase activity.

Jayne S, Kerfelec B, Foglizzo E, Chapus C, Crenon I.

Biochim Biophys Acta. 2002 Feb 11;1594(2):255-65.

PMID:
11904221
38.

Insecticidal proteins from Bacillus thuringiensis protect corn from corn rootworms.

Moellenbeck DJ, Peters ML, Bing JW, Rouse JR, Higgins LS, Sims L, Nevshemal T, Marshall L, Ellis RT, Bystrak PG, Lang BA, Stewart JL, Kouba K, Sondag V, Gustafson V, Nour K, Xu D, Swenson J, Zhang J, Czapla T, Schwab G, Jayne S, Stockhoff BA, Narva K, Schnepf HE, Stelman SJ, Poutre C, Koziel M, Duck N.

Nat Biotechnol. 2001 Jul;19(7):668-72.

PMID:
11433280
39.

Pancreatic lipase-related protein type 1: a double mutation restores a significant lipase activity.

Crenon I, Jayne S, Kerfelec B, Hermoso J, Pignol D, Chapus C.

Biochem Biophys Res Commun. 1998 May 19;246(2):513-7.

PMID:
9610393
40.

Expression of a chimeric CaMV 35S Bacillus thuringiensis insecticidal protein gene in transgenic tobacco.

Carozzi NB, Warren GW, Desai N, Jayne SM, Lotstein R, Rice DA, Evola S, Koziel MG.

Plant Mol Biol. 1992 Nov;20(3):539-48. Erratum in: Plant Mol Biol 1993 Jan;21(2):413.

PMID:
1285798
41.

Promoter cassettes, antibiotic-resistance genes, and vectors for plant transformation.

Rothstein SJ, Lahners KN, Lotstein RJ, Carozzi NB, Jayne SM, Rice DA.

Gene. 1987;53(2-3):153-61.

PMID:
3609746
42.

A cauliflower mosaic virus promoter directs expression of kanamycin resistance in morphogenic transformed plant cells.

Koziel MG, Adams TL, Hazlet MA, Damm D, Miller J, Dahlbeck D, Jayne S, Staskawicz BJ.

J Mol Appl Genet. 1984;2(6):549-62.

PMID:
6099400

Supplemental Content

Support Center